NextConsensus // Decision-window intelligence

Know when the window to defend a claim is closing.

Evidence hardens before institutions act. We identify the evidence patterns that determine the Ratification Gap — so you can defend your position before the window closes.

For market access, medical affairs, and launch teams: know when a disputed claim has reached a stable hardening pattern—and whether it is ready for institutional recognition.

One Claim To Defend / Support
One Decision Formulary / Coverage
Window Status Open / Narrowing

01 // THE PROBLEM

Evidence stabilizes before you present.

Evidence hardens before the market catches up. By identifying specific hardening patterns, we identify when a claim is ready for formal recognition—and when the window to defend it is narrowing.

[AUDIT_STATUS: MEASURED] · We identify hardening patterns, what holds, and whether the window to defend is still open.

When this matters:

  • Formulary expansion business cases
  • Payer re-engagement materials
  • Objection handler updates
  • HEOR value dossier support
  • Coverage policy defense

02 // THE OUTPUT

A defense brief your team can forward to market access.

Each brief answers: Can this claim still be challenged, and how much time do we have?

Window status (Open / Narrowing / Closing), what holds, what is under stress, what would reverse the read, and a suggested action envelope for your defense strategy.

Defense Brief Structure For Market Access / HEOR
  • Window Status: Open / Narrowing / Closing
  • What Holds: Stable evidence supporting your claim
  • What Is Under Stress: Counter-evidence you must pre-empt
  • What Would Reverse: Evidence that would weaken your position
  • Suggested Action Envelope: Defense strategy before the window closes
Trust Boundary

We measure the Ratification Gap. We do not predict payer decisions or guarantee coverage success.

Start

Have a claim you need to defend before a decision locks?

Send the claim, the decision date, and your position. We respond within one business day with fit, limits, and whether the window to act is still open.

Requests require a verified institutional email address and are subject to current lane authorization limits.

Today's Read finerenone-cardiorenal
Hardening
Signal 0.38 / Gate 0.65
Phase 1b pending review. Other lanes: dossier-build.

Visual Debug

Page:

Width: px

Theme: